(1888PressRelease) Akermin today announces the signing of a Cooperative Agreement for a commercial-scale demonstration project that will incorporate its biocatalyst technology. This DKK 42 million ($7 million US), three-year demonstration project is partially-funded through a grant from the Danish Energy Agency (EUDP).